Posted by Michael Wonder on 18 Oct 2021
FDA approves naloxone injection to counteract opioid overdoses
18 October 2021 - The FDA has approved Zimhi (naloxone hydrochloride) injection as an additional option to treat opioid overdose.
Zimhi is administered using a single-dose, pre-filled syringe that delivers 5 mg of naloxone hydrochloride solution through intramuscular or subcutaneous injection.
